Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease
Zakaria, A., Sayed, S., Aly, M., Hedeba, W. (2019). Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease. EKB Journal Management System, 74(6), 1428-1432. doi: 10.21608/ejhm.2019.26983
Abdel Monem M. Zakaria; Sameh S. Sayed; Mekky A. Aly; Wael M. Abou Hedeba. "Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease". EKB Journal Management System, 74, 6, 2019, 1428-1432. doi: 10.21608/ejhm.2019.26983
Zakaria, A., Sayed, S., Aly, M., Hedeba, W. (2019). 'Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease', EKB Journal Management System, 74(6), pp. 1428-1432. doi: 10.21608/ejhm.2019.26983
Zakaria, A., Sayed, S., Aly, M., Hedeba, W. Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease. EKB Journal Management System, 2019; 74(6): 1428-1432. doi: 10.21608/ejhm.2019.26983

Macrophage Migration Inhibitory Factor in the Early Diagnosis of Endometriosis and Relationship to the Stage of the Disease

The Egyptian Journal of Hospital Medicine
Article 29, Volume 74, Issue 6, January 2019, Page 1428-1432  XML PDF (302.23 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2019.26983
View on SCiNiTO View on SCiNiTO
Authors
Abdel Monem M. Zakaria1; Sameh S. Sayed1; Mekky A. Aly2; Wael M. Abou Hedeba email 1
1Department of Obstetrics and Gynecology, Faculty of Medicine - Al Azhar University
2Department of Clinical Pathology Faculty of Medicine - Al Azhar University
Abstract
Background: Endometriosis is a chronic disease affecting women of reproductive age. Adolescent onset of symptoms is common. Macrophage migration inhibitory factor (MIF) is one of non-invasive blood biomarker that was found in endometriosis. Aim of the work: to evaluate the value of macrophage MIF in peripheral blood of women with and without endometriosis as a non-invasive early diagnostic method and correlate its level to the stage of the disease. Patient and methods: This observational case-control study was conducted in El-Hussein Hospital, Al-Azhar University, Cairo and private clinics. The study was approved by the local research ethics committee. During the period from May 2016 till July 2018. Results: Both groups were comparable as regard the incidence of infertility and the presence of chronic pelvic pain. The infertility was equal in both groups; it affected 96% of patients and control groups. The chronic pelvic pain was symmetrically present in both groups; it affected 70% of endometriosis and the control group. The level of MIF was 10.03±1.78 pg/ml in patients with endometriosis and 4.82±1.78 pg/ml in control group with significant P value (P <0.001). In our study, the level of MIF differed according to the stage of endometriosis, in stage I, it was 8.6±0.2 pg/ml, in stage II, it was 10.1±0.1 pg/ml, in stage III, it was 11.3±0.2 pg/ml and in stage IV, it was 14+0.0 pg/ml. Conclusion: MIF factor is a promising marker not only for noninvasive diagnosis of endometriosis but as a target for therapy also
Keywords
Macrophage Migration Inhibitory Factor; Endometriosis and Stage of the Disease
Statistics
Article View: 163
PDF Download: 378